Future research should include a longer follow-up to investigate sustained treatment effects, and current evidence does not yet support widespread off-label use of semaglutide for AUD
For urgent concerns, contact your GP, NHS 111, or emergency services if appropriate
Clinical trials have shown that consistent use over several months can lead to significant weight loss, typically maintained after 68 weeks of continuous treatment
The compounding pharmacy industry operates under specific regulations that most consumers know little about, and understanding these standards helps you make informed decisions about your treatment
In some cases, switching to a different GLP-1 agent or adjusting the dosing schedule may provide better tolerability
Adding Ozempic can drop it an additional 1-1.5%